1. Executive Summary2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product & Service: Market Size & Analysis
5.1. Overview
5.2. Instruments
5.3. Reagents & Consumables
6. Screening Type: Market Size & Analysis
6.1. Overview
6.2. Pre-Transplant
6.3. Post-Transplant
7. Organ Type: Market Size & Analysis
7.1. Overview
7.2. Kidney
7.3. Liver
7.4. Heart
7.5. Lung
7.6. Pancreas
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. HOLOGIC, INC. (U.S.)
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. BIOFORTUNA LIMITED (U.K.)
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. TAKARA BIO INC. (JAPAN)
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. ABBOTT (U.S.)
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. DIAGNÓSTICA LONGWOOD SL (SPAIN)
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. ADAPTIVE BIOTECHNOLOGIES (U.S.)
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. NANOSTRING TECHNOLOGIES, INC.(U.S.)
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. ARQUER DIAGNOSTICS LTD (U.K.)
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. F. ALTONA DIAGNOSTICS GMBH (GERMANY)
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. ELITECHGROUP (FRANCE)
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
List of Tables
Table 1. Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 2. Transplant Diagnostics Market Value for Instruments, by Geography, 2021-2030 (USD Billion)
Table 3. Transplant Diagnostics Market Value for Reagents & Consumables, by Geography, 2021-2030 (USD Billion)
Table 4. Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 5. Transplant Diagnostics Market Value for Pre-Transplant, 2021-2030 (USD Billion)
Table 6. Transplant Diagnostics Market Value for Post-Transplant and Oropharyngeal Swabs, 2021-2030 (USD Billion)
Table 7. Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 8. Transplant Diagnostics Market Value for Kidney, by Geography, 2021-2030 (USD Billion)
Table 9. Transplant Diagnostics Market Value for Liver, by Geography, 2021-2030 (USD Billion)
Table 10. Transplant Diagnostics Market Value for Heart, by Geography, 2021-2030 (USD Billion)
Table 11. Transplant Diagnostics Market Value for Lung, by Geography, 2021-2030 (USD Billion)
Table 12. Transplant Diagnostics Market Value for Pancreas, by Geography, 2021-2030 (USD Billion)
Table 13. North America Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Table 14. North America Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 15. North America Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 16. North America Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 17. U.S Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 18. U.S Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 19. U.S Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 20. U.S Transplant Diagnostics Market Value, by Disease Indication, 2021-2030 (USD Billion)
Table 21. Canada Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 22. Canada Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 23. Canada Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 24. Mexico Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 25. Mexico Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 26. Mexico Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 27. Europe Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Table 28. Europe Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 29. Europe Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 30. Europe Transplant Diagnostics Market Value, End Use Industries, 2021-2030 (USD Billion)
Table 31. Germany Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 32. Germany Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 33. Germany Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 34. U.K Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 35. U.K Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 36. U.K Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 37. France Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 38. France Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 39. France Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 40. Italy Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 41. Italy Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 42. Italy Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 43. Spain Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 44. Spain Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 45. Spain Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 46. Roe Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 47. Roe Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 48. Roe Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 49. Asia-Pacific Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Table 50. Asia-Pacific Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 51. Asia-Pacific Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 52. Asia-Pacific Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 53. China Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 54. China Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 55. China Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 56. India Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 57. India Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 58. India Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 59. Japan Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 60. Japan Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 61. Japan Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 62. Rest of APAC Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 63. Rest of APAC Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 64. Rest of APAC Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 65. Latin America Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 66. Latin America Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 67. Latin America Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 68. Brazil Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 69. Brazil Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 70. Brazil Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 71. Argentina Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 72. Argentina Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 73. Argentina Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 74. Middle East and Africa Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 75. Middle East and Africa Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 76. Middle East and Africa Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 77. Saudi Arabia Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 78. Saudi Arabia Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 79. Saudi Arabia Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 80. Uae Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 81. Uae Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 82. Uae Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 83. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Table 84. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Table 85. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Table 86. Hologic, Inc. (U.S.): Financials
Table 87. Hologic, Inc. (U.S.): Products & Services
Table 88. Hologic, Inc. (U.S.): Recent Developments
Table 89. Biofortuna Limited (U.K.): Financials
Table 90. Biofortuna Limited (U.K.): Products & Services
Table 91. Biofortuna Limited (U.K.): Recent Developments
Table 92. Takara Bio Inc. (Japan): Financials
Table 93. Takara Bio Inc. (Japan): Products & Services
Table 94. Takara Bio Inc. (Japan): Recent Developments
Table 95. Abbott (U.S.): Financials
Table 96. Abbott (U.S.): Products & Services
Table 97. Abbott (U.S.): Recent Developments
Table 98. Diagnóstica Longwood Sl (Spain): Financials
Table 99. Diagnóstica Longwood Sl (Spain): Products & Services
Table 100. Diagnóstica Longwood Sl (Spain): Recent Developments
Table 101. Adaptive Biotechnologies (U.S.): Financials
Table 102. Adaptive Biotechnologies (U.S.): Products & Services
Table 103. Adaptive Biotechnologies (U.S.): Recent Developments
Table 104. Nanostring Technologies, Inc.(U.S.): Financials
Table 105. Nanostring Technologies, Inc.(U.S.): Products & Services
Table 106. Nanostring Technologies, Inc.(U.S.): Developments
Table 107. Arquer Diagnostics Ltd (U.K.): Financials
Table 108. Arquer Diagnostics Ltd (U.K.): Products & Services
Table 109. Arquer Diagnostics Ltd (U.K.): Recent Developments
Table 110. F. Altona Diagnostics GmbH (Germany): Financials
Table 111. F. Altona Diagnostics GmbH (Germany): Products & Services
Table 112. F. Altona Diagnostics GmbH (Germany): Recent Developments
Table 113. Elitechgroup (France): Financials
Table 114. Elitechgroup (France): Products & Services
Table 115. Elitechgroup (France): Recent Developments
List of Figures
Chart. 1. Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 2. Transplant Diagnostics Market Value for Instruments, by Geography, 2021-2030 (USD Billion)
Chart. 3. Transplant Diagnostics Market Value for Reagents & Consumables, by Geography, 2021-2030 (USD Billion)
Chart. 4. Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 5. Transplant Diagnostics Market Value for Pre-Transplant, 2021-2030 (USD Billion)
Chart. 6. Transplant Diagnostics Market Value for Post-Transplant and Oropharyngeal Swabs, 2021-2030 (USD Billion)
Chart. 7. Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 8. Transplant Diagnostics Market Value for Kidney, by Geography, 2021-2030 (USD Billion)
Chart. 9. Transplant Diagnostics Market Value for Liver, by Geography, 2021-2030 (USD Billion)
Chart. 10. Transplant Diagnostics Market Value for Heart, by Geography, 2021-2030 (USD Billion)
Chart. 11. Transplant Diagnostics Market Value for Lung, by Geography, 2021-2030 (USD Billion)
Chart. 12. Transplant Diagnostics Market Value for Pancreas, by Geography, 2021-2030 (USD Billion)
Chart. 13. North America Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Chart. 14. North America Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 15. North America Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 16. North America Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 17. U.S Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 18. U.S Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 19. U.S Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 20. U.S Transplant Diagnostics Market Value, by Disease Indication, 2021-2030 (USD Billion)
Chart. 21. Canada Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 22. Canada Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 23. Canada Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 24. Mexico Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 25. Mexico Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 26. Mexico Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 27. Europe Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Chart. 28. Europe Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 29. Europe Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 30. Europe Transplant Diagnostics Market Value, End Use Industries, 2021-2030 (USD Billion)
Chart. 31. Germany Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 32. Germany Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 33. Germany Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 34. U.K Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 35. U.K Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 36. U.K Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 37. France Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 38. France Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 39. France Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 40. Italy Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 41. Italy Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 42. Italy Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 43. Spain Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 44. Spain Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 45. Spain Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 46. Roe Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 47. Roe Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 48. Roe Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 49. Asia-Pacific Transplant Diagnostics Market Value, by Country, 2021-2030 (USD Billion)
Chart. 50. Asia-Pacific Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 51. Asia-Pacific Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 52. Asia-Pacific Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 53. China Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 54. China Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 55. China Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 56. India Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 57. India Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 58. India Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 59. Japan Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 60. Japan Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 61. Japan Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 62. Rest of APAC Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 63. Rest of APAC Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 64. Rest of APAC Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 65. Latin America Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 66. Latin America Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 67. Latin America Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 68. Brazil Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 69. Brazil Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 70. Brazil Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 71. Argentina Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 72. Argentina Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 73. Argentina Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 74. Middle East and Africa Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 75. Middle East and Africa Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 76. Middle East and Africa Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 77. Saudi Arabia Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 78. Saudi Arabia Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 79. Saudi Arabia Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 80. Uae Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 81. Uae Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 82. Uae Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 83. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Product & Service, 2021-2030 (USD Billion)
Chart. 84. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Screening Type, 2021-2030 (USD Billion)
Chart. 85. Rest of Middle East and Africa Transplant Diagnostics Market Value, by Organ Type, 2021-2030 (USD Billion)
Chart. 86. Hologic, Inc. (U.S.): Financials
Chart. 87. Hologic, Inc. (U.S.): Products & Services
Chart. 88. Hologic, Inc. (U.S.): Recent Developments
Chart. 89. Biofortuna Limited (U.K.): Financials
Chart. 90. Biofortuna Limited (U.K.): Products & Services
Chart. 91. Biofortuna Limited (U.K.): Recent Developments
Chart. 92. Takara Bio Inc. (Japan): Financials
Chart. 93. Takara Bio Inc. (Japan): Products & Services
Chart. 94. Takara Bio Inc. (Japan): Recent Developments
Chart. 95. Abbott (U.S.): Financials
Chart. 96. Abbott (U.S.): Products & Services
Chart. 97. Abbott (U.S.): Recent Developments
Chart. 98. Diagnóstica Longwood Sl (Spain): Financials
Chart. 99. Diagnóstica Longwood Sl (Spain): Products & Services
Chart. 100. Diagnóstica Longwood Sl (Spain): Recent Developments
Chart. 101. Adaptive Biotechnologies (U.S.): Financials
Chart. 102. Adaptive Biotechnologies (U.S.): Products & Services
Chart. 103. Adaptive Biotechnologies (U.S.): Recent Developments
Chart. 104. Nanostring Technologies, Inc.(U.S.): Financials
Chart. 105. Nanostring Technologies, Inc.(U.S.): Products & Services
Chart. 106. Nanostring Technologies, Inc.(U.S.): Developments
Chart. 107. Arquer Diagnostics Ltd (U.K.): Financials
Chart. 108. Arquer Diagnostics Ltd (U.K.): Products & Services
Chart. 109. Arquer Diagnostics Ltd (U.K.): Recent Developments
Chart. 110. F. Altona Diagnostics GmbH (Germany): Financials
Chart. 111. F. Altona Diagnostics GmbH (Germany): Products & Services
Chart. 112. F. Altona Diagnostics GmbH (Germany): Recent Developments
Chart. 113. Elitechgroup (France): Financials
Chart. 114. Elitechgroup (France): Products & Services
Chart. 115. Elitechgroup (France): Recent Developments